SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: olivier benrubi who wrote (36)11/7/2000 12:31:28 PM
From: tuck  Read Replies (2) | Respond to of 1784
 
Olivier,

CEREP sort of fits, but I would not call it a paradigmatic trickle stock. Emphasis chiefly on discovery. Not sure how big their assay business is. Do you have some more links to financial statements and a reliable source for a quote?

CYTO. Again, sort of. Proteomics division doesn't have anything on the market yet. Next year.

May have to test the SI portfolio interface on foreign (specifically TSE) quotes. MDZ won't budge on the NYSE.

Cheers, Tuck